Lexaria Bioscience Corp.

LEXXNasdaq· Pharmaceutical Preparations

Price History

Revenue

$705,923

▲ 52.0% YoY

Net Income

-$11.9M

▼ 105.4% YoY

EPS

$-0.66

▼ 40.4% YoY

Cash

$1.8M

▼ 72.3% YoY

FY 2025 · As of 2025-08-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.